Učitavanje...

A Multi-Objective Approach for Anti-Osteosarcoma Cancer Agents Discovery through Drug Repurposing

Osteosarcoma is the most common type of primary malignant bone tumor. Although nowadays 5-year survival rates can reach up to 60–70%, acute complications and late effects of osteosarcoma therapy are two of the limiting factors in treatments. We developed a multi-objective algorithm for the repurposi...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Pharmaceuticals (Basel)
Glavni autori: Cabrera-Andrade, Alejandro, López-Cortés, Andrés, Jaramillo-Koupermann, Gabriela, González-Díaz, Humberto, Pazos, Alejandro, Munteanu, Cristian R., Pérez-Castillo, Yunierkis, Tejera, Eduardo
Format: Artigo
Jezik:Inglês
Izdano: MDPI 2020
Teme:
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7700154/
https://ncbi.nlm.nih.gov/pubmed/33266378
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ph13110409
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!